News Image

IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting

Provided By PR Newswire

Last update: Dec 10, 2025

Abstracts presented include 3 studies involving 263 patients, adding to a growing body of evidence across diverse patient populations supporting broader adoption of ProSense®

Read more at prnewswire.com

ICECURE MEDICAL LTD

NASDAQ:ICCM (12/17/2025, 8:00:02 PM)

After market: 0.68 0 (0%)

0.68

+0.05 (+8.68%)



Find more stocks in the Stock Screener

Follow ChartMill for more